Delivery Order SPE2DB22D3004-SPE2DB25FQB65

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,014.82, is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price, delivery order contract. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,636.56 firm fixed-price delivery order is for the medication TOVIAZ ER 4 MG TABLET 30S. The contract has a completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,778.94 firm-fixed-price delivery order is for the supply of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support...
This federal contract award is a delivery order valued at $1,222.74 for the pharmaceutical product TOVIAZ ER 4 MG TABLET 30S. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 22, 2025 and is a firm fixed price arrangement. The contract does not have a set-aside designation, indicating it was competitively...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,763.99 firm-fixed-price delivery order is for the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as...
The U.S. government awarded a Firm Fixed Price Delivery Order contract worth $6,581.51 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract covers the delivery of TOVIAZ ER 4 MG TABLET 30S, a medication used for overactive bladder treatment. This order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,354.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The contract is for the delivery of TOVIAZ ER 4 MG TABLET 30S, a...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUSJ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,262.25 firm-fixed-price delivery order is for the provision of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
The Defense Logistics Agency Troop Support Medical awarded a $3,060.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561375776 TOVIAZ ER 8 MG TABLET 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. No major subcontractors or set aside designations were identified. This delivery order appears to be calling off products from an...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D1004) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,817.58. The contract is for the delivery of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQB65
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,543.65, is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/26/25, 9:50 AM